Is thrombin suppression adequate with low-dose heparin and eptifibatide versus high-dose heparin in patients undergoing peripheral percutaneous interventions?

Autor:	V. Takes, J.H. Lemke, Nicolas W. Shammas, T. Palabrica, EJ Dippel, H.L. Kirchner, Jon Robken
Rok vydání:	2006
Předmět:	Percutaneous business.industry General Medicine Heparin medicine.disease Peripheral Thrombin Anesthesia medicine Eptifibatide In patient Medical emergency Cardiology and Cardiovascular Medicine business Low dose heparin medicine.drug
Zdroj:	Cardiovascular Revascularization Medicine. 7:82
ISSN:	1553-8389
DOI:	10.1016/j.carrev.2006.03.005
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::815b5202fc4946179f4cff58f7555cf3 https://doi.org/10.1016/j.carrev.2006.03.005 Zobrazit plný text záznamu Full Text from ScienceDirect